Artificial Intelligence Technology Solutions Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Artificial Intelligence Technology Solutions Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Feb 28, 2023 | $1.33M | Jun 14, 2023 |
| FY2023 | Feb 28, 2022 | $1.45M | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | $360.9K | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $260.8K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $114.7K | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | $106.5K | Nov 4, 2019 |
| FY2015 | Feb 28, 2015 | $6.8K | Jun 15, 2015 |
| FY2014 | Feb 28, 2014 | $87.4K | Jul 3, 2014 |
| FY2014 | Feb 28, 2013 | $114.0K | Jul 3, 2014 |
| FY2013 | Feb 29, 2012 | $72.3K | Jun 25, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $6.13M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $2.23M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $1.33M | May 29, 2024 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Feb 28, 2015 | $6.8K | Jun 21, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $3.74M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $565.8K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $653.9K | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $974.2K | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | $262.7K | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $177.0K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $110.1K | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | $61.5K | Nov 4, 2019 |
| FY2015 | Feb 28, 2015 | $6.8K | Jun 15, 2015 |
| FY2014 | Feb 28, 2014 | $19.1K | Jul 3, 2014 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($18.94M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($20.71M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($18.11M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($62.20M) | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | ($5.90M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($6.21M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $16.09M | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | ($24.25M) | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | ($83.9K) | Jun 22, 2018 |
| FY2018 | Dec 31, 2016 | ($81.1K) | Jun 22, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($13.95M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($13.99M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($12.69M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($13.37M) | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | ($2.99M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($1.78M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($3.41M) | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | ($3.52M) | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | ($81.2K) | Jun 22, 2018 |
| FY2018 | Dec 31, 2016 | ($79.9K) | Jun 22, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $3.46M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $3.45M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $3.63M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $2.96M | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | $378.2K | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $332.5K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $541.0K | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | $493.0K | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | $20.2K | Jun 22, 2018 |
| FY2018 | Dec 31, 2016 | $30.6K | Jun 22, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Feb 28, 2015 | $595.7K | Jun 15, 2015 |
| FY2015 | Feb 28, 2014 | $575.3K | Jun 15, 2015 |
| FY2014 | Feb 28, 2013 | $348.8K | Jul 3, 2014 |
| FY2013 | Feb 29, 2012 | $4.11M | Jun 25, 2014 |
| FY2011 | Feb 28, 2011 | $35.1K | Jun 13, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($12.20M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($12.95M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($12.58M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($14.83M) | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | ($3.07M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($1.54M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($1.80M) | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | ($3.31M) | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | ($225.2K) | Jun 22, 2018 |
| FY2018 | Dec 31, 2016 | ($58.7K) | Jun 22, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $23.7K | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $22.2K | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $258.4K | May 29, 2024 |
| FY2016 | Feb 28, 2015 | $30.0K | Jun 21, 2016 |
| FY2013 | Feb 29, 2012 | $23.3K | Jun 25, 2014 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $10.99M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $7.60M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $6.30M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $9.28M | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | $1.57M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $343.6K | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $591.0K | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | $736.6K | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | $341.2K | Jun 22, 2018 |
| FY2017 | Feb 29, 2016 | $9.4K | Jun 19, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | $60.51M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | $47.80M | May 29, 2025 |
| FY2024 | Feb 28, 2023 | $38.14M | May 29, 2024 |
| FY2023 | Feb 28, 2022 | $30.26M | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | $16.11M | May 31, 2022 |
| FY2021 | Feb 29, 2020 | $21.45M | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | $16.42M | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | $35.00M | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | $506.3K | Jun 22, 2018 |
| FY2017 | Feb 29, 2016 | $1.58M | Jun 19, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($49.93M) | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($40.20M) | May 29, 2025 |
| FY2025 | Feb 28, 2023 | ($31.84M) | May 29, 2025 |
| FY2024 | Feb 28, 2022 | ($20.98M) | May 29, 2024 |
| FY2023 | Feb 28, 2021 | ($14.54M) | Jun 14, 2023 |
| FY2022 | Feb 29, 2020 | ($21.11M) | May 31, 2022 |
| FY2021 | Feb 28, 2019 | ($15.83M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2018 | ($34.26M) | Jul 31, 2020 |
| FY2019 | Feb 28, 2017 | ($165.0K) | Nov 4, 2019 |
| FY2018 | Dec 31, 2016 | ($81.1K) | Jun 22, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Feb 28, 2013 | $54.7K | Jul 26, 2013 |
| FY2011 | Feb 29, 2012 | $108.7K | Jun 13, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | ($156.50M) | May 29, 2025 |
| FY2025 | Mar 1, 2024 | $4.18M | May 29, 2025 |
| FY2025 | Feb 29, 2024 | ($132.96M) | May 29, 2025 |
| FY2024 | Feb 28, 2023 | ($112.25M) | May 29, 2024 |
| FY2023 | Feb 28, 2022 | ($94.14M) | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | ($31.52M) | May 31, 2022 |
| FY2021 | Feb 29, 2020 | ($25.62M) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | ($19.41M) | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | ($35.50M) | Nov 4, 2019 |
| FY2018 | Feb 28, 2017 | ($184.7K) | Jun 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Feb 28, 2022 | $4.65M | May 31, 2022 |
| FY2022 | Feb 28, 2021 | $1.04M | May 31, 2022 |
| FY2022 | Feb 29, 2020 | $13.3K | May 31, 2022 |
| FY2021 | Feb 28, 2019 | $21.2K | Jun 1, 2021 |
| FY2020 | Feb 28, 2018 | $24.8K | Jul 31, 2020 |
| FY2019 | Feb 28, 2017 | $56.9K | Nov 4, 2019 |
| FY2018 | Dec 31, 2016 | $49.6K | Jun 22, 2018 |
| FY2017 | Feb 29, 2016 | $2.2K | Jun 19, 2017 |
| FY2017 | Feb 28, 2015 | $2.7K | Jun 19, 2017 |
| FY2016 | Feb 28, 2014 | $30.2K | Jun 21, 2016 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Feb 28, 2015 | $1.52M | Jun 15, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 0 | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 0 | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | 0 | May 31, 2022 |
| FY2021 | Feb 29, 2020 | (31) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | 5,804 | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | 0 | Nov 4, 2019 |
| FY2017 | Feb 28, 2017 | 4 | Jun 19, 2017 |
| FY2017 | Feb 29, 2016 | 0 | Jun 19, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 0 | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 0 | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 0 | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 0 | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | 0 | May 31, 2022 |
| FY2021 | Feb 29, 2020 | (31) | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | (46) | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | 0 | Nov 4, 2019 |
| FY2017 | Feb 28, 2017 | 0 | Jun 19, 2017 |
| FY2017 | Feb 29, 2016 | 0 | Jun 19, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Feb 28, 2025 | 14.41B | May 29, 2025 |
| FY2025 | Feb 29, 2024 | 9.24B | May 29, 2025 |
| FY2024 | Feb 28, 2023 | 5.85B | May 29, 2024 |
| FY2023 | Feb 28, 2022 | 4.74B | Jun 14, 2023 |
| FY2022 | Feb 28, 2021 | 3.23B | May 31, 2022 |
| FY2021 | Feb 29, 2020 | 418,415 | Jun 1, 2021 |
| FY2020 | Feb 28, 2019 | 20,026 | Jul 31, 2020 |
| FY2019 | Feb 28, 2018 | 1.25M | Nov 4, 2019 |
| FY2017 | Feb 28, 2017 | 17.66M | Jun 19, 2017 |
| FY2017 | Feb 29, 2016 | 4.91M | Jun 19, 2017 |